Table 2.
In vivo anti-tumor effect of different PTX formulations in A2780-bearing mice
| group | Weight of tumor (g) | Inhibition rate (%) |
|---|---|---|
| saline | 4.32±0.35 | - |
| Free PTX | 3.40±0.28 | 21.2±3.3 |
| LP-PTX | 2.94±0.27 | 32.1±2.2 |
| T7-LP-PTX | 1.47±0.12 | 66.4±5.4 |
In vivo anti-tumor effect of different PTX formulations in A2780-bearing mice
| group | Weight of tumor (g) | Inhibition rate (%) |
|---|---|---|
| saline | 4.32±0.35 | - |
| Free PTX | 3.40±0.28 | 21.2±3.3 |
| LP-PTX | 2.94±0.27 | 32.1±2.2 |
| T7-LP-PTX | 1.47±0.12 | 66.4±5.4 |